T3 Pharmaceuticals
Basel
About T3 Pharmaceuticals
The vision of T3 Pharmaceuticals is to improve the lives of cancer patients with highly innovative treatments. Despite significant advances of classical therapies, there remains a high need for novel and innovative medicines to treat cancer. T3 Pharmaceuticals is dedicated to fill this gap by developing highly specific and efficient treatments using live bacteria.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $39.0M
- Funding stage: M&A
- Last round: Grant (Apr 2023)
- Website: t3pharma.com
- Phone: +410612672074
Industries & Categories
Biotechnology, Life Science, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/t3-pharmaceuticals-130495 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.